US 11267845
Inhibitors of CD73-mediated immunosuppression
granted A61KA61K45/06A61P
Quick answer
US patent 11267845 (Inhibitors of CD73-mediated immunosuppression) held by Arcus Biosciences, Inc. expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arcus Biosciences, Inc.
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K45/06, A61P, A61P1/04, A61P1/18